The Suppressive Effect of Supplementation of Combined Probiotic on Helicobacter pylori Infection. (29th May 2020)

• Record Type: Journal Article
• Authors: Huang, Shih-Chien; Lei, Yen-Ping; Lin, Ching-Pin; Hsiao, Pei-Wen; Chi, Ya-Ting
• Is Part Of: Current developments in nutrition. Volume 4(2020)Supplement 2
• Page Start: 1565
• Page End: 1565
• Publication Date: 2020-05-29
• Subjects: Nutrition -- Periodicals; Nutritional Physiological Phenomena; Nutrition; Periodicals; Periodicals; Fulltext; Internet Resources; Periodicals; 612.3
• DOI: 10.1093/cdn/nzaa062_022
• Languages: English
• ISSNs: 2475-2991

Abstract

Abstract: Objectives: Helicobacter pylori (H. pylori) is the leading cause of chronic gastritis and gastric ulcers and significantly increases the risk of developing gastric cancer. Even though many therapeutic improvements in H. pylori eradication rate, it is still associated with the high prevalence of infection. Several studies have verified that probiotics treatment were beneficial to gastrointestinal tract infections is increasingly documented as an alternative to antibiotics. This study aimed to investigate the efficacy of novelty probiotic complex on H. pylori infection in patients. Methods: Between October 2018 and August 2019, all subjects with a clinical of Chung Shan Medical University Hospital in Taiwan, subjects who confirmed H. pylori infection (n = 20) were randomized to receive probiotic complex or placebo for 3 weeks. The probiotic complex contained Lactobacillus johnsonii No.1088 (HK-LJ88) 10 10 CFU/mL, Bacillus subtilis 10 12 CFU/mL, green tea extract and sake lees. Primary outcome of this study was The amounts of change of 13 C urea breath test ( 13 C UBT) that was assessed 3 weeks after the end of supplementation. The hematological results, dietary records, anthropogenic indicators were measured/assessed at the 0 and 3 th week. Results: Subjects in the probiotic group had significantly lower 13 C UBT (39.6%) at the 3 th week when compared to the value at week 0. In contrast with subjects in the placebo group had higher 50% 13 C UBT. The levels of anthropometric indices, blood glucose and lipid profiles had no significant changes during the intervention study period in both groups. After adjusting for age and gender, supplement had significant effect on reducing the change of 13 C UBT (β = -13.64, p = 0.047) and diastolic blood pressure (β = -6.91, p = 0.03). Conclusions: These results suggest that supplement with the combination of probiotic Lactobacillus johnsonii and Bacillus subtilis for 3 weeks may have a favorable effect on H. pylori infection in humans. The probiotics intervention also resulted in improved blood pressure. Funding Sources: Yang Ming Biomed Co., Ltd.